Your signal. Your price.

Dariush Mozaffarian says his 11 years of medical training included almost no practical nutrition education, despite diet being a major health risk; he argues nutrition science must shape medical care and public policy.
Mozaffarian argues saturated fat is an incomplete guide to health: its effects vary by fatty-acid type, food, and replacement, while LDL remains a cardiovascular risk factor alongside blood pressure, inflammation, glucose, and activity.
Milk fat globule membrane can affect cholesterol absorption and gut microbes, helping explain why butter, cheese, cream, and milk may affect LDL differently. In a randomized trial, cream did not raise LDL after eight weeks, while butter did.
Mozaffarian places yogurt and other fermented dairy above eggs, poultry, and butter, with unprocessed red meat lower and processed meat lowest. He links processed meats to stroke, diabetes, and cancer, and red meat more consistently to type 2 diabetes and distal colorectal cancer than heart disease.
Mozaffarian says one or two weekly servings of unprocessed red meat are probably fine, while frequent intake is less advisable, especially alongside a poor diet. Heme iron and compounds formed during cooking or through gut microbes may contribute to diabetes and colorectal cancer risk.
Mozaffarian says omega-3 fats, especially from seafood, and omega-6 fats are beneficial in human evidence; he rejects claims that omega-6 fats cause inflammation. Plant and seafood fats generally beat butter, while repeatedly heated or burned oils can form harmful oxidation products.
Mozaffarian traces nutrient-focused guidelines to vitamin-deficiency crises and wartime food policy, then describes the Green Revolution as a famine response that favored crop yield over nutritional diversity. He says modern crop varieties can contain substantially fewer nutrients than older varieties.
Mozaffarian says low-fat guidelines encouraged manufacturers to replace fat with additives that changed food texture and taste. He also links the rise of ultra-processed foods to tobacco companies applying their marketing and product-development methods to food brands.
Mozaffarian says ultra-processing can break food's cellular structure, speed nutrient absorption, deprive gut microbes of substrates, and shift more calories to human tissues. Additives, contaminants, and hyper-palatable formulations may also affect health, though their individual effects vary.
Mozaffarian says a whole-grain claim does not guarantee intact grain structure: commercial breads and cereals can be milled and reassembled, making them faster to digest than steel-cut oats. He recommends checking whether food is recognizable and comparing fiber with total carbohydrate.
Mozaffarian says refined starch intake rose sharply as obesity began increasing, while calorie intake later flattened and physical activity rose. He argues declining resting energy expenditure, potentially tied to reduced thermogenesis and diet-driven changes in brown fat, may help explain continued weight gain.
Mozaffarian says exercise can reduce visceral fat and improve metabolic health without much change in body weight. He favors gradual weight loss through diet quality over calorie counting, noting that low-fat weight-loss diets can suppress resting energy expenditure more than higher-fat, lower-starch diets.
Mozaffarian says GLP-1 drugs work best as an adjunct to nutrition and lifestyle support, not as a standalone weight-loss strategy. Many users stop treatment, and weight regain can leave people with less muscle and bone; he favors pairing prescriptions with ongoing counseling.
Mozaffarian says recent U.S. dietary guidelines shift toward real food, healthy fats, and whole-fat dairy, while warning against processed foods and artificial additives. He supports yogurt and cheese, says dairy fat content is less important than processing and added sugar, and criticizes protein-fortified junk foods.
Mozaffarian calls for stronger FDA review of food additives and closure of the GRAS loophole, alongside better nutrition research and incentives for healthier food. He cites small nutrition budgets, large federal food programs, and state restrictions as opportunities to redirect policy toward minimally processed foods.
Mozaffarian defines food as medicine as food's ability to affect bodily systems, not as a replacement for drugs or clinical care. He argues policy should make nourishing food affordable and available through healthcare, research, and food-system incentives.
Patrick explains that blueberry polyphenols do not simply act as direct antioxidants. Instead, human and gut microbiota enzymes transform these compounds into active signaling metabolites that regulate processes like nitric oxide production, gene expression, and inflammation.
Patrick highlights a 2025 meta-analysis of nine clinical trials showing that daily blueberry consumption improves episodic and language-related memory in older adults suffering from mild cognitive impairment or subjective cognitive decline.
Patrick points out that long-term observational data from the Nurses' Health Study linked consuming at least half a cup of blueberries weekly to a slower rate of cognitive decline, equivalent to being 1.5 to 2.5 years cognitively younger.
Patrick highlights a Framingham cohort analysis showing that regular blueberry consumption is associated with a 50 percent lower risk of dementia. Additionally, high dietary intake of anthocyanins correlates with a 76 percent lower risk of Alzheimer's disease.
Patrick contrasts the Framingham findings with a Danish cohort study showing only a 16 percent lower dementia risk. Patrick attributes this discrepancy to Framingham's superior methodology of measuring diet repeatedly over several years.
Patrick points out that daily consumption of one cup of blueberries improves flow-mediated dilation by 1 to 1.5 percentage points. Meta-analyses show each single percentage point improvement in flow-mediated dilation correlates with a 12 percent lower risk of cardiovascular events.
Patrick details a six-month trial where adults with metabolic syndrome consuming one cup of blueberries daily saw improved flow-mediated dilation and a 2.24 percentage point decrease in arterial stiffness. A half-cup daily dose failed to produce these vascular benefits.
Patrick references human mechanistic experiments showing that gut enzymes metabolize blueberry anthocyanins into 63 distinct circulating compounds. Among these, 14 metabolites were directly associated with immediate improvements in flow-mediated dilation, illustrating a highly active systemic response.
Patrick points out that while a six-week trial of two cups of blueberries daily improved insulin sensitivity by 22 percent in obese adults, a replication study conducted by Patrick's team failed to reproduce this exact glycemic outcome.
Patrick explains that blueberry proanthocyanins are poorly absorbed in the small intestine, allowing them to reach the colon intact. Once there, they interact with the microbiome, support the mucosal barrier, and increase muc2 protein expression in animal models by 150 percent.
Patrick highlights a crossover study of patients with gastrointestinal disorders where consuming 30 grams of freeze-dried blueberry powder daily led to clinically meaningful abdominal symptom relief in 53 percent of participants, compared to 30 percent in the placebo group.
Patrick explains that blueberries do not directly improve athletic performance or mitigate immediate muscle damage. Instead, consuming one cup daily shifts post-exercise lipid signals to resolve acute inflammation more efficiently, accelerating muscle strength recovery after strenuous workouts.
Patrick warns that blending blueberries with high-polyphenol oxidase ingredients like bananas can degrade beneficial compounds. Bananas have 136 times more polyphenol oxidase activity than avocados, and this enzyme directly oxidizes chlorogenic acid, subsequently destroying blueberry anthocyanins.
Patrick cites a 2023 study demonstrating that blending a high-polyphenol oxidase banana smoothie with cocoa extract reduced circulating epicatechin-derived metabolites by 84 percent. Consuming a low-polyphenol oxidase berry smoothie maintained metabolite levels comparable to taking capsules.